ROCKVILLE, Md., Nov. 4 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2008 third quarter financial results in a press release to be issued after 8:00 a.m. Eastern Time on November 10, 2008. The Company will hold an investor conference call to discuss its financial results at 10:00 a.m. Eastern Time on November 10, 2008. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of senior management. A question and answer session will follow the financial results overview. The dial-in number for the conference call is USA and Canada (866) 793-1308 International: (703) 639-1310.
A live audio webcast of the conference call will be available at http://www.novavax.com. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the webcast will be available for 90 days after the webcast and a replay of the conference call will also be available by telephone beginning 1pm EST. November 10, 2008 through midnight November 13, 2008. To access the replay, dial (888) 266-2081 and enter pass code 1290008.
About Novavax, Inc.
Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.
Forward Looking Statements
Statements herein relating to future development results and
performance, conditions or strategi
|SOURCE Novavax, Inc.|
Copyright©2008 PR Newswire.
All rights reserved